Home Stocks Getein Biotech, Inc. Class A Shareholders Getein Biotech, Inc. Class A · SSE:603387
Getein Biotech, Inc. Class A shareholders Getein Biotech, Inc. Class A on 6ix: holders from US fund reports. Largest: State Street(R) SPDR(R) Portfolio Emerging Markets ETF, Acadian Emerging Markets Portfolio and Emerging Markets Core Equity 2 Portfolio. Each with its filing.
Shareholders Holder Shares Value Change As of State Street(R) SPDR(R) Portfolio Emerging Markets ETF 642K US$715K No change Jun 30, 2026 Acadian Emerging Markets Portfolio 641K US$845K New Jul 31, 2026 Emerging Markets Core Equity 2 Portfolio 198K US$261K −40,000 Jul 31, 2026 State Street(R) SPDR(R) S&P(R) China ETF 80,228 US$89,352 −3,200 Jun 30, 2026 Dimensional Emerging Core Equity Market ETF 52,900 US$69,715 +7,600 Jul 31, 2026 The Emerging Markets Small Cap Series 45,600 US$60,108 No change Jul 31, 2026 Dimensional Emerging Markets Value Fund 36,800 US$48,508 New Jul 31, 2026 Dimensional Emerging Markets Core Equity 2 ETF 35,600 US$46,916 No change Jul 31, 2026 Dimensional Emerging Markets Value ETF 33,800 US$44,543 No change Jul 31, 2026 Dimensional World ex. U.S. Core Equity 2 ETF 31,000 US$40,854 No change Jul 31, 2026 State Street(R) SPDR(R) S&P(R) Emerging Asia Pacific ETF 27,128 US$30,213 +2,000 Jun 30, 2026 Emerging Markets Social Core Equity Portfolio 16,600 US$21,881 New Jul 31, 2026 Emerging Markets Sustainability Core 1 Portfolio 9,212 US$12,143 No change Jul 31, 2026 World ex U.S. Core Equity Portfolio 8,036 US$10,593 No change Jul 31, 2026